Elisabetta Bigagli
Overview
Explore the profile of Elisabetta Bigagli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1042
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bigagli E, Spataro E, Pasquini L, Cinci L, DAmbrosio M, De Blasi C, et al.
Placenta
. 2025 Mar;
163:8-15.
PMID: 40023010
Introduction: Fetal growth restriction (FGR) is associated with increased risk of neonatal morbidity and mortality or long-term adverse outcomes. We investigated the ability of hypoxia and angiogenesis-related miR-210-3p and miR-126-5p...
2.
Curti L, Rizzi B, Mottarlini F, Bigagli E, Ilari A, Costa A, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2024 Oct;
136():111174.
PMID: 39447689
Background: Prenatal alcohol exposure (PAE) induces a wide range of neurodevelopmental disabilities that are grouped under the term 'fetal alcohol spectrum disorders' (FASD). The effects of PAE on brain development...
3.
Rocca B, Bigagli E, Cerbai E
Cardiovasc Drugs Ther
. 2024 Sep;
38(6):1103-1109.
PMID: 39348077
Polypharmacy is often necessary in complex, chronic, comorbid and cardiovascular patients and is a known risk factor for potential drug-drug interaction (DDI) that can cause adverse reactions (toxicity or therapeutic...
4.
Gerace E, Curti L, Caffino L, Bigagli E, Mottarlini F, Castillo Diaz F, et al.
Eur J Pharmacol
. 2023 Jul;
955:175878.
PMID: 37433363
Prenatal alcohol exposure (PAE) affects neuronal networks and brain development causing a range of physical, cognitive and behavioural disorders in newborns that persist into adulthood. The array of consequences associated...
5.
DAmbrosio M, Bigagli E, Cinci L, Gencarelli M, Chioccioli S, Biondi N, et al.
Mar Drugs
. 2023 May;
21(5).
PMID: 37233497
Pre-metabolic syndrome (pre-MetS) may represent the best transition phase to start treatments aimed at reducing cardiometabolic risk factors of MetS. In this study, we investigated the effects of the marine...
6.
Bigagli E, Agostiniani S, Pugi A, Rombi B, Tornaboni E, Censullo M, et al.
Front Pediatr
. 2023 Mar;
11:1145941.
PMID: 36896395
In immunocompetent individuals, cytomegalovirus (CMV) infection is usually mild but may cause severe complications such as retinitis, pneumonitis, and encephalitis in immunocompromised individuals. So far, cases of CMV retinitis in...
7.
Bigagli E, DAmbrosio M, Cinci L, Fiorindi C, Agostiniani S, Bruscoli E, et al.
Nutrients
. 2023 Feb;
15(4).
PMID: 36839239
Several international guidelines recommend a peri-operative immunonutrition (IN) support for patients care in elective colorectal surgery, to reduce postoperative complications, particularly infections. In Crohn's patients, is also used to mitigate...
8.
Terzic V, Levoyer L, Figarella M, Bigagli E, Mercier N, de Gastines L, et al.
Br J Clin Pharmacol
. 2023 Jan;
89(4):1318-1328.
PMID: 36680782
Setting-up a high quality, compliant and efficient pharmacovigilance (PV) system in multi-country clinical trials can be more challenging for academic sponsors than for companies. To ensure the safety of all...
9.
Ageno W, Bertu L, Bucherini E, Camporese G, Dentali F, Iotti M, et al.
BMJ
. 2022 Dec;
379:e072623.
PMID: 36520715
Objective: To compare two different treatment durations of rivaroxaban in patients with symptomatic isolated distal deep vein thrombosis (DVT). Design: Randomised, double blind, placebo controlled clinical trial. Setting: 28 outpatient...
10.
Bigagli E, Lodovici M, Vasarri M, Peruzzi M, Nassi N, DeglInnocenti D
Antioxidants (Basel)
. 2022 Aug;
11(8).
PMID: 36009216
Congenital central hypoventilation syndrome (CCHS) is a rare neurological genetic disorder that affects sleep-related respiratory control. Currently, no drug therapy is available. In light of this, there is a need...